bevacizumab monoclonal antibody drug. angiogenesis inhibitor targeting vegf-a, used to treat cancer and age-related macular

age amd angiogenesis antibody bevacizumab biological biosimilar biotech biotechnology blood breast cancer colorectal degeneration disease drug endothelial eye factor growth humanized immunoglobulin immunology infusion injection inn intravitreal lung mab macular monoclonal neovascular nomenclature offlabel oncology ophthalmologist ophthalmology peptide protein recombinant related tumor vascular vessel vitreous